Department of Neuroscience, Box 593, 751 24 Uppsala, Sweden.
CNS Neurol Disord Drug Targets. 2013 Sep;12(6):768-72. doi: 10.2174/18715273113126660168.
Neuropathic pain is a serious consequence of injury or disease in the nervous system itself. Current treatment options for this condition are often unsatisfactory. From being originally viewed as a diseased caused by neuronal dysfunction, a growing body of evidence implicate activated microglia as a key player in the development of this pain condition. In this review, some of the evidence for this proposal is briefly discussed and placed in a translational context, pointing out the difficulties in translating commonly used animal models of neuropathic pain to the clinical condition, as well as emphasizing the broader role of activated microglia in the injured or diseased nervous system.
神经病理性疼痛是神经系统本身损伤或疾病的严重后果。目前对此病症的治疗选择往往不尽人意。最初,这种病症被认为是由神经元功能障碍引起的疾病,但越来越多的证据表明,激活的小胶质细胞是这种疼痛病症发展的关键因素。在这篇综述中,简要讨论了这一观点的部分证据,并将其置于转化背景下,指出将常用于神经病理性疼痛的动物模型转化为临床病症所面临的困难,同时强调了激活的小胶质细胞在受伤或患病的神经系统中的更广泛作用。